Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Checkpoint Therapeutics ( (CKPT) ) just unveiled an announcement.
Checkpoint Therapeutics, Inc. has entered into an executive employment agreement with Garrett Gray, its Chief Financial Officer. The agreement includes terms for salary, bonuses, long-term incentives, and severance benefits, particularly in cases of termination, resignation, or changes in control, ensuring stability and structured financial planning for both the executive and the company.
More about Checkpoint Therapeutics
YTD Price Performance: -2.43%
Average Trading Volume: 1,456,239
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $156.8M
Learn more about CKPT stock on TipRanks’ Stock Analysis page.